News + Filings Charts Holdings
|
Rathbones Group PLC
> ADAP
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Adaptimmune Therapeutics PLC | ADAP | 432,818 | 0 | 400,356,000 | -71,415,000 | $925.00 |
03/31/2023 | Adaptimmune Therapeutics PLC | ADAP | 432,818 | 0 | 471,771,000 | -160,143,000 | $1,090.00 |
12/31/2022 | Adaptimmune Therapeutics PLC | ADAP | 432,818 | 0 | 631,914,000 | 631,449,000 | $1,460.00 |
09/30/2022 | Adaptimmune Therapeutics PLC | ADAP | 432,818 | 0 | 465,000 | -271,000 | $1.07 |
06/30/2022 | Adaptimmune Therapeutics PLC | ADAP | 432,818 | 0 | 736,000 | -156,000 | $1.70 |
03/31/2022 | Adaptimmune Therapeutics PLC | ADAP | 432,818 | 0 | 892,000 | -731,000 | $2.06 |
12/31/2021 | Adaptimmune Therapeutics PLC | ADAP | 432,818 | -103 | 1,623,000 | -615,000 | $3.75 |
09/30/2021 | Adaptimmune Therapeutics PLC | ADAP | 432,921 | 0 | 2,238,000 | 394,000 | $5.17 |
06/30/2021 | Adaptimmune Therapeutics PLC | ADAP | 432,921 | 0 | 1,844,000 | -489,000 | $4.26 |
12/31/2020 | Adaptimmune Therapeutics PLC | ADAP | 432,921 | 0 | 2,333,000 | -1,122,000 | $5.39 |
09/30/2020 | Adaptimmune Therapeutics PLC | ADAP | 432,921 | -10,000 | 3,455,000 | -979,000 | $7.98 |
06/30/2020 | Adaptimmune Therapeutics PLC | ADAP | 442,921 | 44,068 | 4,434,000 | 3,349,000 | $10.01 |
03/31/2020 | Adaptimmune Therapeutics PLC | ADAP | 398,853 | -303,722 | 1,085,000 | 242,000 | $2.72 |
12/31/2019 | Adaptimmune Therapeutics PLC | ADAP | 702,575 | 0 | 843,000 | -218,000 | $1.20 |
09/30/2019 | Adaptimmune Therapeutics PLC | ADAP | 702,575 | -1,897 | 1,061,000 | -1,771,000 | $1.51 |
06/30/2019 | Adaptimmune Therapeutics PLC | ADAP | 704,472 | 418,750 | 2,832,000 | 1,603,000 | $4.02 |
03/31/2019 | Adaptimmune Therapeutics PLC | ADAP | 285,722 | 62,292 | 1,229,000 | -56,000 | $4.30 |
12/31/2018 | Adaptimmune Therapeutics PLC | ADAP | 223,430 | 0 | 1,285,000 | -1,745,000 | $5.75 |
09/30/2018 | Adaptimmune Therapeutics PLC | ADAP | 223,430 | -20,000 | 3,030,000 | 140,000 | $13.56 |
06/30/2018 | Adaptimmune Therapeutics PLC | ADAP | 243,430 | 0 | 2,890,000 | 156,000 | $11.87 |
03/31/2018 | Adaptimmune Therapeutics PLC | ADAP | 243,430 | -69,500 | 2,734,000 | 644,000 | $11.23 |
12/31/2017 | Adaptimmune Therapeutics PLC | ADAP | 312,930 | -8,120 | 2,090,000 | -539,000 | $6.68 |
09/30/2017 | Adaptimmune Therapeutics PLC | ADAP | 321,050 | 120,525 | 2,629,000 | 1,729,000 | $8.19 |
06/30/2017 | Adaptimmune Therapeutics PLC | ADAP | 200,525 | 0 | 900,000 | -205,000 | $4.49 |
03/31/2017 | Adaptimmune Therapeutics PLC | ADAP | 200,525 | 0 | 1,105,000 | 293,000 | $5.51 |
12/31/2016 | Adaptimmune Therapeutics PLC | ADAP | 200,525 | -129,600 | 812,000 | -1,515,000 | $4.05 |
09/30/2016 | Adaptimmune Therapeutics PLC | ADAP | 330,125 | -120,400 | 2,327,000 | -1,345,000 | $7.05 |
06/30/2016 | Adaptimmune Therapeutics PLC | ADAP | 450,525 | 450,525 | 3,672,000 | 3,672,000 | $8.15 |
03/31/2016 | Adaptimmune Therapeutics PLC | ADAP | 200,525 | 200,525 | 1,630,000 | 1,630,000 | $8.13 |
12/31/2015 | Adaptimmune Therapeutics PLC | ADAP | 200,525 | 200,525 | 1,514,000 | 1,514,000 | $7.55 |
<< Prev Next >> |
|